---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-002125"
form_type: "8-K"
ticker: "GALT"
cik: "0001133416"
company_name: "GALECTIN THERAPEUTICS INC"
filed_at: "2025-01-28T23:59:59+00:00"
generated_at: "2026-05-27T07:57:07.326358+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Galectin Therapeutics elects all 11 director nominees, ratifies auditor at 2024 annual meeting

## Summary
- All 11 director nominees elected with votes for ranging from 18.2M to 19.0M; broker non-votes of 20.0M.
- Ratification of Cherry Bekaert LLP as auditor: 38.7M for, 162.8K against, 408.9K abstain.
- Annual meeting held January 23, 2025; directors elected for term until next annual meeting.

## SEC filing metadata
- accession: 0001140361-25-002125
- form_type: 8-K
- ticker: GALT
- cik: 0001133416
- company_name: GALECTIN THERAPEUTICS INC
- filed_at: 2025-01-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133416/000114036125002125/0001140361-25-002125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133416/000114036125002125/ef20042347_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-002125
- JSON: https://secwatch.observer/filing/0001140361-25-002125.json
- Plain text: https://secwatch.observer/filing/0001140361-25-002125.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.